SCHEMBL20176513

SCHEMBL20176513

c1ccc(-c2ccc(-c3c4ccccc4c(-c4ccc(-c5ccc(-c6ccc7c(c6)c6ccc8ccccc8c6n7-c6ccccc6)cc5)nc4)c4ccccc34)cc2)cc1

nearest known ligand 0.34

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
MTOR P42345 4/20 0.34
NR3C1 P04150 1/20 0.32
HSD17B1 P14061 1/20 0.32
HSD17B2 P37059 1/20 0.32
CYP11B1 P15538 1/20 0.32
CYP11B2 P19099 1/20 0.32
KMT2A Q03164 1/20 0.32
PIK3CD O00329 3/20 0.31
PIK3CA P42336 3/20 0.31
MAPK10 P53779 1/20 0.31
KHK P50053 1/20 0.31
HPGDS O60760 1/20 0.30
IDO1 P14902 1/20 0.30
TDO2 P48775 1/20 0.30
PLG P00747 1/20 0.30
PLAU P00749 1/20 0.30
ESR1 P03372 1/20 0.30
ESR2 Q92731 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26160957 1.00 MTOR (0.34) MTORNR3C1HSD17B1HSD17B2CYP11B1
SCHEMBL20176538 0.97 HSD17B1 (0.33) MTORNR3C1HSD17B1HSD17B2CYP11B1
SCHEMBL26160955 0.96 HSD17B1 (0.33) MTORHSD17B1HSD17B2CYP11B1CYP11B2
SCHEMBL26161042 0.95 NR3C1 (0.33) MTORNR3C1HSD17B1HSD17B2KMT2A
SCHEMBL26161223 0.95 NR3C1 (0.33) MTORNR3C1HSD17B1HSD17B2KMT2A
SCHEMBL26161225 0.95 NR3C1 (0.33) MTORNR3C1HSD17B1HSD17B2KMT2A
SCHEMBL26161040 0.94 HSD17B1 (0.33) MTORNR3C1HSD17B1HSD17B2KMT2A
SCHEMBL20176495 0.89 HSD17B1 (0.33) MTORHSD17B1HSD17B2CYP11B1CYP11B2
SCHEMBL26160954 0.88 HSD17B1 (0.34) MTORHSD17B1HSD17B2CYP11B1CYP11B2
SCHEMBL26161222 0.87 KHK (0.34) MTORNR3C1HSD17B1HSD17B2KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11667622-B2 Organic light emitting compound and organic electroluminescence device using same SOLUS ADVANCED MATERIALS CO., LTD. (KR) 2023-06-06 US disclosed
US-11667622-B2 Organic light emitting compound and organic electroluminescence device using same SOLUS ADVANCED MATERIALS CO., LTD. (KR) 2023-06-06 US disclosed
WO-2018093231-A1 ORGANIC LIGHT EMITTING COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE USING SAME 주식회사 두산 2018-05-24 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11667622-B2 Organic light emitting compound and organic electroluminescence device using same OR10J3, ICMT, SLCO4C1 MTOR 4229/4885NR3C1 4170/4885HSD17B1 1993/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.